Skip to main content
Ikonisys S.A. logo

Ikonisys S.A. — Investor Relations & Filings

Ticker · ALIKO ISIN · FR00140048X2 LEI · 9695000B742KPNDQ4D05 PA Manufacturing
Open in API
Filings indexed 195 across all filing types
Latest filing 2022-10-14 AGM Information
Country FR France
Listing PA ALIKO

About Ikonisys S.A.

https://www.ikonisys.com

Ikonisys S.A. is a cell-based diagnostics company specializing in Fluorescence in Situ Hybridization (FISH) technology for genetic analysis. The company develops, manufactures, and markets integrated solutions that include proprietary automated microscopy instruments, advanced software, and reagents. These systems are designed to improve efficiency, accuracy, and standardization for pathologists and laboratory technicians. Ikonisys's technology enables the precise detection and analysis of chromosomal alterations, supporting early and accurate cancer diagnosis, prognosis, and the selection and monitoring of personalized therapies. The platform's automation and digitization features streamline the entire workflow from image acquisition to quantitative interpretation for oncology and genetic testing applications.

Recent filings

Filing Released Lang Actions
Informations privilégiées / Autres communiqués
AGM Information Classification · 99% confidence The document title explicitly states "compte rendu de l'assemblé générale extraordinaire du 6 octobre 2022" (report of the extraordinary general meeting of October 6, 2022). The content confirms that all resolutions presented at the General Meeting were adopted unanimously. This directly relates to the proceedings and outcomes of a shareholder meeting. The most appropriate classification is AGM-R (AGM Information), which covers presentations and materials shared during the Annual General Meeting (or Extraordinary General Meeting, as the context implies meeting materials/outcomes). Although it reports the results, it is the summary/report of the meeting itself, not just the voting results (DVA) or a proxy solicitation (PSI).
2022-10-14 French
Inside Information / Other news releases
Capital/Financing Update Classification · 99% confidence The document is an official announcement dated October 5, 2022, detailing that Ikonisys SA has signed a financing agreement of up to €5.1 million structured as convertible bonds (OCA) with attached warrants (BSA). It explicitly mentions the drawdown of a first tranche and details the legal framework, characteristics of the securities (OCA and BSA), conversion/exercise formulas, and the impact on share capital and shareholder stakes. This content directly relates to fundraising, capital structure changes, and the issuance of new securities, which aligns perfectly with the 'Capital/Financing Update' definition.
2022-10-06 English
Informations privilégiées / Autres communiqués
Capital/Financing Update Classification · 99% confidence The document is a press release dated October 5, 2022, announcing that Ikonisys SA has signed a financing agreement for up to €5.1 million structured as convertible bonds with warrants (OCABSA) and has drawn down the first tranche of €500,000. The text details the legal framework, characteristics of the OCA and BSA instruments, conversion ratios, exercise prices, and the theoretical dilution impact on existing shareholders. This content directly relates to fundraising, capital structure changes, and the issuance of new securities (convertible debt and warrants). This aligns perfectly with the definition of 'Capital/Financing Update' (CAP). It is not an Annual Report (10-K), an Earnings Release (ER), or a simple Dividend Notice (DIV). Since it is the primary announcement detailing the financing terms, it is classified as CAP, not just a Report Publication Announcement (RPA).
2022-10-06 French
Inside Information / Other news releases
Regulatory Filings Classification · 100% confidence The document is a press release announcing a specific business event: the installation of the Ikoniscope20 solution at a US urology laboratory. It contains a headline, date, company boilerplate, quotes from management, and contact information. This type of announcement, which details operational achievements, sales wins, or strategic milestones outside of mandatory financial reporting periods (like 10-K, IR, or ER), typically falls under general regulatory announcements or news releases. Since it is not a formal financial report (10-K, IR), an earnings release (ER), a management discussion (MDA), or a specific corporate action like a dividend (DIV) or share transaction (POS), the most appropriate general category for a significant, non-financial operational update that is publicly disclosed is 'Regulatory Filings' (RNS), which serves as a broad category for official company news releases that don't fit elsewhere. The document length (4674 chars) is substantial enough to be the primary announcement, not just a brief RPA.
2022-09-26 English
Informations privilégiées / Autres communiqués
Regulatory Filings Classification · 100% confidence The document is a press release dated September 26, 2022, announcing a specific business event: the installation of the Ikoniscope20 solution in a leading US urology lab. It details a commercial achievement and includes quotes from management. This type of announcement, which is not a formal regulatory filing (like 10-K, IR, or ER) but rather a general corporate update intended for investors and the public, fits best under the 'Regulatory Filings' (RNS) category as a general corporate announcement, or potentially a 'Capital/Financing Update' (CAP) if it were related to fundraising, which it is not. Since it is a specific, non-standard announcement about a business development (a sale/installation), and does not fit the definitions for ER, IR, or other specific financial reports, RNS (Regulatory Filings - general regulatory announcements/miscellaneous filings) is the most appropriate fallback classification for this type of press release.
2022-09-26 French
Inside Information / Other news releases
Capital/Financing Update Classification · 98% confidence The document is a press release announcing the mutual termination of a financing agreement between Ikonisys and Negma Group. This type of announcement, which details a change in the company's financial structure or funding arrangements (specifically the end of a financing program), aligns best with the 'Capital/Financing Update' category. It is not a full annual report (10-K), an earnings release (ER), or a management discussion (MDA). Since it directly concerns financing activities, CAP is the most appropriate code. The document length (4128 chars) is substantial enough to be the primary announcement, not just a brief RPA.
2022-09-20 English

Browse filings by year

6 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.